Evidence map›Paper›PMID 31394914›Full record

Trial reportAnnals of the American Thoracic Society2019

Polysomnographic Endotyping to Select Patients with Obstructive Sleep Apnea for Oral Appliances.

Ahmad A Bamagoos, Peter A Cistulli, Kate Sutherland, Melanie Madronio, Danny J Eckert, Lauren Hess, Bradley A Edwards, Andrew Wellman, Scott A Sands

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of the American Thoracic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis.American journal of respiratory and critical care medicine · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Trial
  7. Trial
  8. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. The upper airway in obstructive sleep apnoea: state of the art.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Ahmad A BamagoosSleep Research Group, Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-7142-081X
Peter A CistulliSleep Research Group, Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.
Kate SutherlandSleep Research Group, Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.
Melanie MadronioCentre for Sleep Health and Research, Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Danny J EckertSleep and Breathing Lab, Neuroscience Research Australia (NeuRA), Randwick, New South Wales, Australia.ORCID 0000-0003-3503-2363
Lauren HessDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Bradley A EdwardsSleep and Circadian Medicine Laboratory, Department of Physiology, and.ORCID 0000-0001-9383-1644
Andrew WellmanDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Scott A SandsDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Funding

Validation of a Phenotype Model to Predict Response to Alternative OSA TreatmentsR01HL102321 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WELLMAN, DAVID ANDREW · 2011 to 2025
$7.3M
NHLBI NIH HHS R01 HL102321
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Orthodontic AppliancesAdultAirway ObstructionAirway ResistanceCross-Over StudiesFemaleHumansMaleMiddle AgedMultivariate AnalysisPharynxPolysomnographyRegression AnalysisSeverity of Illness IndexSleep Apnea, ObstructiveTreatment Outcomemandibular advancement splintsphenotypeprecision medicinesleep-disordered breathingtargeted therapy

Identifiers

PMID31394914
PMCPMC6945467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.